Robbins and Cotran pathologic basis of disease. W B Saunders Co. Read it at Google Books - Find it at Amazon 2. Primer of diagnostic imaging.
|Published (Last):||7 August 2013|
|PDF File Size:||7.1 Mb|
|ePub File Size:||3.28 Mb|
|Price:||Free* [*Free Regsitration Required]|
Ear infections that are slow to resolve. Recurrent otitis media. Decrease in hearing. Eye Inflammation can occur in different parts of the eye. Pictured below is a computed tomography CAT scan of the eyes in a patient with a retro—orbital mass a mass behind the eye in a man with Granulomatosis with Polyangiitis. Masses such as these sometimes cause an abrupt loss of vision through stretching or compression of the optic nerve, which enters the back of the eye.
Nose Nasal crusting and frequent nosebleeds can occur. Erosion and perforation of the nasal septum. Pictured below is an example of this deformity before and after cosmetic surgery. This resulted from the collapse of the nasal septum caused by cartilage inflammation. This patient has Granulomatosis with Polyangiitis, but an identical lesion may occur in Relapsing Polychondritis. Sinuses Chronic sinus inflammation that sometimes leads to a destructive process of tissues around the sinuses.
This narrowing, caused by inflammation and scarring, causes difficulty breathing and may, after a subacute progression, necessitate emergency tracheostomy. Bleeding from the lungs can occur. Kidney Inflammation can occur in the kidney, leading to small or rarely, large amounts of blood and protein in the urine.
This condition is called glomerulonephritis. Renal masses can occur, but are very unusual in this disease. The image below is from a urinalysis of a patient with kidney inflammation. Skin Granulomatosis with Polyangiitis can cause many kinds of skin rashes.
Joints Arthritis can occur, with joint swelling and pain. Nerves Peripheral nerve involvement leads to numbness, tingling, shooting pains in the extremities, and sometimes to weakness in a foot, hand, arm, or leg. Miscellaneous Granulomatosis with Polyangiitis involvement of nearly all organs has been described, including the meninges the layers of protective tissue around the brain and spinal cord , the prostate gland, and the genito—urinary tract.
In addition to involving specific organs, Granulomatosis with Polyangiitis also commonly results in generalized symptoms of fatigue, low—grade fever, and weight loss.
The cause of Granulomatosis with Polyangiitis is not known. Compared to diseases with obvious genetic predispositions, genetics appear to play a relatively small role in the etiology of Granulomatosis with Polyangiitis. It is very unusual for Granulomatosis with Polyangiitis to occur in two people in the same family.
It is possible, however, that less obvious genetic risk factors exist, e. For some time, an infection has been suspected of causing or at least contributing to Granulomatosis with Polyangiitis , but no specific infection bacterial, viral, fungal, or other has been identified. How is Granulomatosis with Polyangiitis Diagnosed? Whenever possible, it is important to confirm the diagnosis of Granulomatosis with Polyangiitis by biopsying an involved organ and finding the pathologic features of this disease under the microscope.
Because many diseases may mimic Granulomatosis with Polyangiitis and vice versa , before starting a treatment regimen it is essential to be as certain of the diagnosis as possible. We discuss some of the specific biopsy procedures used to diagnose Granulomatosis with Polyangiitis in the section of this Websie entitled What is Vasculitis: Diagnosis?
Therefore, sometimes more invasive procedures are required to make the diagnosis. Lung biopsy either open or thoracoscopic is often the best way of diagnosing Granulomatosis with Polyangiitis. The ample amount of tissue obtainable through these procedures usually permits confirmation of the Granulomatosis with Polyangiitis diagnosis.
Since , when ANCAs anti—neutrophil cytoplasmic antibodies were first described, the role of these antibodies in the diagnosis of Granulomatosis with Polyangiitis has grown.
ANCA testing, which involves the performance of a simple blood test, has achieved wide availability during the s. This is both good and bad: use of ANCA tests has led to earlier diagnoses and more rapid institution of appropriate treatment in many cases, but has also resulted in misdiagnosis and incorrect treatment when the tests are not performed or interpreted correctly.
As their name implies, ANCAs are directed against the cytoplasm the non-nucleus part of white blood cells. Their precise role in the disease process remains uncertain but is a topic of considerable research interest. When C—ANCAs are present in the blood of a patient whose symptoms or signs suggest Granulomatosis with Polyangiitis , the likelihood of the diagnosis increases considerably.
Treatment and Course of Granulomatosis with Polyangiitis Until the s, Granulomatosis with Polyangiitis was nearly always a fatal condition. The first use of cyclophosphamide in the late s began to change the terrible prognosis of this disease.
Unfortunately, Granulomatosis with Polyangiitis is a disease in which relapses frequently occur. Flares of Granulomatosis with Polyangiitis are usually responsive to the same treatment that induced remission, but sometimes intensification of treatment for example, changing to a more powerful medication is required.
During the s, physicians have increasingly used the combination of methotrexate and prednisone rather than cyclophosphamide and prednisone for Granulomatosis with Polyangiitis patients who do not have immediately life-threatening disease particularly disease that does not involve the kidneys severely , because of the frequency of severe side-effects associated with the latter regimen.
Bactrim or Septra , a combination of two antibiotics trimethoprim and sulfamethoxazole may also be helpful in the treatment of Granulomatosis with Polyangiitis , particularly in patients whose disease is limited primarily to the upper respiratory tract.
A large, multi-center study demonstrated that Bactrim is useful in preventing flares of Granulomatosis with Polyangiitis in the upper respiratory tract. In the past few years, significant advances have been made in understanding Granulomatosis with Polyangiitis , although many important questions remain.
In addition to an improved understanding of how to use the currently available medicines for Granulomatosis with Polyangiitis , it is likely that the next few years will witness the development of new medicines for this disease. Scientific breakthroughs may lead to the design of more specific modulators of the immune system that are of great benefit to patients with Granulomatosis with Polyangiitis. In medical terms, by David Hellmann, M. The American College of Physicians has given us permission to make this information available to patients contacting our Website Granulomatosis with Polyangiitis is a disease involving granulomatous inflammation, necrosis and vasculitis that most frequently targets the upper respiratory tract, lower respiratory tract, and kidneys.
Although Granulomatosis with Polyangiitis can begin at any age, the average age of onset is about 40 years. Other organs frequently affected by Granulomatosis with Polyangiitis granulomatosis include the eye proptosis and double-vision from retro-orbital pseudotumor, scleritis , skin ulcers, purpura. Granulomatosis with Polyangiitis may be limited to one site for many months or years before disseminating. Systemic symptoms fever, fatigue, weight loss are also common. Anemia, mild leukocytosis, and elevated Erythrocyte sedimentation rate ESR are nonspecific laboratory findings.
Chest radiographs often show infiltrates, nodules, masses, or cavities; only hilar adenopathy is incompatible with the diagnosis of Granulomatosis with Polyangiitis. CT of the chest is more sensitive than chest radiography and can be abnormal when the chest radiograph is negative.
Glomerulonephritis causes hematuria, erythrocyte casts, and proteinuria. A novel group of autoantibodies, ANCAs, helps support the diagnosis of Granulomatosis with Polyangiitis and related forms of vasculitis and gives insight into the pathogenesis of these diseases. ANCAs are directed against enzymes cantained in primary granules of neutrophils and monocytes. Two main types of ANCAs are recognized. The C-ANCAs are directed against serine proteinase 3 and are relatively sensitive and highly specific for Granulomatosis with Polyangiitis.
The P-ANCAs are directed against myeloperoxidase and other antigens and are not specific for any single form of vasculitis, but have been seen in some patients with Granulomatosis with Polyangiitis, polyarteritis nodosa, Churg-Strauss vasculitis, and some forms of pauci-immune glomerulonephritis referred to as microscopic polyarteritis nodosa.
Some patients with pulmonary-renal syndromes that may not fit the critieria for Granulomatosis with Polyangiitis are also seropositive for ANCAs. Some patients with inflammatory bowel disease, rheumatoid arthritis, or SLE may have atypical P-ANCA test results, based on the autoantibodies directed against other neutrophil constituents such as lactoferrin. ANCAs may be not only markers for Granulomatosis with Polyangiitis and related disorders, but they may also be actors in pathogenesis.
Studies show that when neutrophils are exposed to cytokines such as tumor necrosis factor, small amounts of serine proteinase and myeloperoxidase, the targets for ANCAs, are expressed on the surface of neutrophils. Adding ANCAs to these cytokine-primed neutrophils causes them to generate oxygen radicals and release enzymes capable of damaging blood vessels.
The diagnosis of Granulomatosis with Polyangiitis is established most securely by biopsy specimens showing the triad of vasculitis, granulomata, and large areas of necrosis known as geographic necrosis admixed with acute and chronic inflammatory cells.
Only large sections of lung tissue obtained via thoracoscopic or open lung biopsy are likely to show all of the histologic features. However, more easily obtained biopsy specimens of the nose, or sinuses may show several of the changes that are highly suggestive of Granulomatosis with Polyangiitis. Such a biopsy specimen combined with a compatible clinical picture and seropositivity for C-ANCAs should suffice to secure the diagnosis. Untreated Granulomatosis with Polyangiitis is fatal.
Prednisone may slow progression of the disease but by itself is insufficient to arrest the disease. Respiratory tract disease usually progresses slowly, but renal disease can progress rapidly and therefore warrants urgent evaluation and treatment. Short-term toxicity includes cytopenia, infection, and hemorrhagic cystitis.
Long-term use of cyclophosphamide in patients with Granulomatosis with Polyangiitis more than doubles the risk of cancer overall, increases the risk of bladder cancer fold and the risk of lymphoma fold.
Monthly intravenous cyclophosphamide appears less toxic but also less effective. Weekly, methotrexate appears to be an effective alternative for Granulomatosis with Polyangiitis that is not immediately life-threatening, and it also appears to be beneficial in maintaining remission. The role of trimethoprim-sulfamethoxazole in treating active disease is controversial, with some finding it effective for Granulomatosis with Polyangiitis limited to the respiratory tract, and others not.
In patients who have achieved remission, trimethoprim-sulfamethoxazole reduces the relapse rate. Use of this Site All information contained within the Johns Hopkins Vasculitis website is intended for educational purposes only. Physicians and other health care professionals are encouraged to consult other sources and confirm the information contained within this site. Consumers should never disregard medical advice or delay in seeking it because of something they may have read on this website.
Granulomatosis con poliangeítis
Welcome to EPOS™!